Home  >  Products  >  TNFRSF17 (tumor necrosis factor receptor superfamily, member 17 ) Blocking Peptide (the C terminal of TNFRSF17)(100ug)
TNFRSF17 (tumor necrosis factor receptor superfamily, member 17 ) Blocking Peptide (the C terminal of TNFRSF17)(100ug)

TNFRSF17 (tumor necrosis factor receptor superfamily, member 17 ) Blocking Peptide (the C terminal of TNFRSF17)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TNFRSF17 Antibody (ARP63927_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63927
Size: 100ug
Weight: 20kDa
Gene: 608
Format: Lyophilized powder
Target: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation.
Alternative names: BCM; BCMA; CD269
See Full Product Listings >